Navigation Links
Xolair Reduces Seasonal Asthma Attacks for Inner City Kids: Study
Date:3/16/2011

By Serena Gordon
HealthDay Reporter

WEDNESDAY, March 16 (HealthDay News) -- The injectable medication Xolair reduced asthma symptoms in inner city children with the respiratory condition, and almost eliminated seasonal peaks in asthma attacks, new research shows.

When added to standard asthma treatments, Xolair (omalizumab) decreased the amount of inhaled steroid needed to maintain asthma control, according to the study, which is published in the March 17 issue of the New England Journal of Medicine.

"Omalizumab improves asthma control on top of guidelines-based treatment," said study co-author Dr. William Busse, a professor of medicine at the University of Wisconsin School of Medicine in Madison. "There was less need for other medications, a reduction of symptoms and reduction of the seasonal exacerbations of asthma. Omalizumab almost totally eliminated these attacks."

But, he added, it's too soon to make treatment recommendations based on these findings. "I think we have to be very cautious, given the limited aspect of our study. It's still a small study, with just 200 people in each group," he explained.

And, he noted, Xolair is an expensive medication, costing about $1,000 a month. Injection of the drug also requires a doctor visit.

Omalizumab targets the antibody immunoglobulin E (IgE), a substance that is responsible for allergic symptoms and many asthma exacerbations. It is given by injection, usually once every two to four weeks, according to Novartis, the drug manufacturer. Omalizumab is currently only approved for people over the age of 12.

The U.S. Food and Drug Administration is currently conducting a long-term safety review of omalizumab, because there have been reports of an increased risk of heart attack, abnormal heart rhythms, heart failure and stroke in people taking the drug. Final results of this review aren't expected until 2012, and, in the meantime, the medicatio
'/>"/>

Copyright©2010 ScoutNews,LLC.
All rights reserved  

Page: 1 2 3

Related medicine news :

1. Mediterranean Diet Reduces Risk of Metabolic Syndrome
2. Aging in place preserves seniors independence, reduces care costs, MU researchers find
3. Perinatal safety initiative reduces adverse obstetrical outcomes
4. Higher volume reduces false positives in screening mammography
5. Adherence course reduces hypertension
6. Smoking during radiation treatments reduces chance of overall survival
7. Estrogen reduces aggression in breast cancer
8. Study finds that electronic fetal heart rate monitoring greatly reduces infant mortality
9. Non-dopaminergic drug preladenant reduces motor fluctuations in patients with Parkinsons disease
10. Extra testosterone reduces your empathy
11. Surgery for obstructive sleep apnea reduces daytime drowsiness
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Xolair Reduces Seasonal Asthma Attacks for Inner City Kids: Study
(Date:8/21/2014)... Spring, Md. (PRWEB) August 21, 2014 ... to Houston with an Education Forum for PH ... disease. , Who:    The Pulmonary Hypertension Association ... works to find ways to prevent and cure ... lungs that affects the functioning of the heart ...
(Date:8/21/2014)... -- Researchers have pinpointed the environmental source of fungal ... California for decades. It literally grows on trees. , ... a 13-year-old girl, who spent the summer gathering soil ... hit by infections of the fungus named Cryptococcus ... , which encompasses a number of species including ...
(Date:8/21/2014)... 2014 (HealthDay News) -- Black mothers are less likely ... one possible reason why: Hospitals in neighborhoods with many ... in areas with more white residents, a U.S. government ... much less common in medical centers where the black ... Centers for Disease Control and Prevention reported Thursday. ...
(Date:8/21/2014)... seniors, dimming vision may be tied to poorer survival, new ... aged 65 to 84, who were assessed when they enrolled ... later. Vision loss over time was associated with an ... period, the researchers reported. Although the study couldn,t prove ... University in West Lafayette, Ind., offered up some theories on ...
(Date:8/21/2014)... (PRWEB) August 21, 2014 Transvaginal ... Bard, Inc. continue to move forward in the ... Southern District of West Virginia, Bernstein Liebhard LLP ... August 14th, the Court has established new stipulated ... special handling, division, storage and preservation. (In re ...
Breaking Medicine News(10 mins):Health News:Pulmonary Hypertension Association Goes On the Road to Houston With an Education Forum for PH Patients and Families to Help Fight Rare Lung Disease 2Health News:Pulmonary Hypertension Association Goes On the Road to Houston With an Education Forum for PH Patients and Families to Help Fight Rare Lung Disease 3Health News:Fungus deadly to AIDS patients found to grow on trees 2Health News:Racial Disparities in Breast-Feeding May Start With Hospitals, Study Suggests 2Health News:Failing Vision Tied to Shorter Lifespans for Seniors 2Health News:Transvaginal Mesh Lawsuits Move Forward in Federal C.R. Bard Litigation with Issuance of New Pretrial Order, Bernstein Liebhard LLP Reports 2Health News:Transvaginal Mesh Lawsuits Move Forward in Federal C.R. Bard Litigation with Issuance of New Pretrial Order, Bernstein Liebhard LLP Reports 3
... , YOUNGTOWN, Ariz., Dec. 3 The ... it has acquired SunView Care Center, an operating skilled nursing ... to Arizona,s Sun City retirement community. The acquisition was effective ... , "We are pleased to be adding a new facility ...
... DC The study of tobacco has been the life-long ... director of the Lombardi Comprehensive Cancer Center at Georgetown University ... of Cancer Epidemiology, Biomarkers & Prevention ( CEBP ... researchers the world over. The December issue of ...
... , ... new market research report is available in its catalogue: ... , http://www.reportlinker.com/p0166820/Sterilization-Technologies-The-US-Market.html , Details the North ... in 2008, and forecasts the market,s compound annual growth ...
... , NEW YORK, Dec. 2 ... available in its catalogue: , Point of Care Diagnostics ... and analysis of the point of care (POC) diagnostics industry ... diagnostics industry , Covers federal regulation of POC testing ...
... , SEOUL, South Korea, Dec. 2 ... Seoul, Korea Telecom (KT), MacroEye and Qualcomm Incorporated (Nasdaq: ... expansion of a project that provides mobile devices, services and ... supplies mobile handsets and devices to caregivers and senior citizens ...
... for advanced cases, study finds , WEDNESDAY, Dec. 2 ... rates for advanced lung cancer patients in the United ... , Researchers analyzed data on more than 100,000 patients ... between 1990 and 2005. The patient information was in ...
Cached Medicine News:Health News:The Ensign Group Acquires Arizona Skilled Nursing Facility 2Health News:Lombardi's Shields leads special journal focused on tobacco research 2Health News:Reportlinker Adds Sterilization Technologies: The U.S. Market 2Health News:Reportlinker Adds Sterilization Technologies: The U.S. Market 3Health News:Reportlinker Adds Sterilization Technologies: The U.S. Market 4Health News:Reportlinker Adds Sterilization Technologies: The U.S. Market 5Health News:Reportlinker Adds Sterilization Technologies: The U.S. Market 6Health News:Reportlinker Adds Sterilization Technologies: The U.S. Market 7Health News:Reportlinker Adds Sterilization Technologies: The U.S. Market 8Health News:Reportlinker Adds Sterilization Technologies: The U.S. Market 9Health News:Reportlinker Adds Sterilization Technologies: The U.S. Market 10Health News:Reportlinker Adds Sterilization Technologies: The U.S. Market 11Health News:Reportlinker Adds Sterilization Technologies: The U.S. Market 12Health News:Reportlinker Adds Sterilization Technologies: The U.S. Market 13Health News:Reportlinker Adds Point of Care Diagnostics 2Health News:Reportlinker Adds Point of Care Diagnostics 3Health News:Reportlinker Adds Point of Care Diagnostics 4Health News:Reportlinker Adds Point of Care Diagnostics 5Health News:Reportlinker Adds Point of Care Diagnostics 6Health News:Reportlinker Adds Point of Care Diagnostics 7Health News:Reportlinker Adds Point of Care Diagnostics 8Health News:Reportlinker Adds Point of Care Diagnostics 9Health News:Reportlinker Adds Point of Care Diagnostics 10Health News:Reportlinker Adds Point of Care Diagnostics 11Health News:Reportlinker Adds Point of Care Diagnostics 12Health News:Qualcomm, City of Seoul, Korea Telecom and MacroEye Leverage the Power of 3G to Connect Low Income and Disabled Senior Citizens to Caregivers 2Health News:Qualcomm, City of Seoul, Korea Telecom and MacroEye Leverage the Power of 3G to Connect Low Income and Disabled Senior Citizens to Caregivers 3Health News:Qualcomm, City of Seoul, Korea Telecom and MacroEye Leverage the Power of 3G to Connect Low Income and Disabled Senior Citizens to Caregivers 4Health News:Gains Made in Lung Cancer Survival 2
(Date:8/21/2014)... Aug. 21, 2014   Royal Philips ... announced it has received 510(k) clearance from the ... precision planning application for Transcatheter Aortic-Valve Implantation (TAVI) ... provides interventionalists with pre-procedural, high-precision positioning to treat ... planning application is available as part of Philips ...
(Date:8/21/2014)... CHESTERBROOK, Pa. , Aug. 21, 2014 /PRNewswire/ ... AUXL ), a specialty biopharmaceutical company, today announced ... study of collagenase clostridium histolyticum (or CCH) for ... known as cellulite. In the Phase 2a trial, ... (0.48mg) and high (0.84mg)) showed an improvement in ...
(Date:8/20/2014)... , Aug. 20, 2014 The National ... the latest results achieved by the real-time, pseudoephedrine ... the National Precursor Log Exchange (NPLEx), automatically blocks ... track down meth offenders and make arrests. Data ... Kansas blocked the sale of ...
Breaking Medicine Technology:Philips receives FDA 510(k) Clearance for TAVI Precision Treatment Planning Application 2Philips receives FDA 510(k) Clearance for TAVI Precision Treatment Planning Application 3Auxilium Pharmaceuticals, Inc. Announces Positive Data From Phase 2a Study Of CCH In Patients With Cellulite 2Auxilium Pharmaceuticals, Inc. Announces Positive Data From Phase 2a Study Of CCH In Patients With Cellulite 3Auxilium Pharmaceuticals, Inc. Announces Positive Data From Phase 2a Study Of CCH In Patients With Cellulite 4Auxilium Pharmaceuticals, Inc. Announces Positive Data From Phase 2a Study Of CCH In Patients With Cellulite 5Auxilium Pharmaceuticals, Inc. Announces Positive Data From Phase 2a Study Of CCH In Patients With Cellulite 6Auxilium Pharmaceuticals, Inc. Announces Positive Data From Phase 2a Study Of CCH In Patients With Cellulite 7Kansas's Stop-Sale System Achieves Significant Results In Battle Against Meth 2
... Pharmaceuticals, Inc. (Nasdaq: ALXA ) announced today that ... Drug Administration (FDA or Agency) for the AZ-004 New Drug ... the meeting.  In December 2010, Alexza held the End-of-Review meeting ... October 2010.  A CRL is issued by FDA,s Center for ...
... The United States continues to lead the world in its ... , but emerging markets led by China, India and Brazil ... resources and activity overseas, according to a new PwC report ... . While the United States is expected to maintain its ...
Cached Medicine Technology:Alexza Pharmaceuticals Completes End-of-Review Meeting With FDA for AZ-004 (Staccato® Loxapine) NDA 2Alexza Pharmaceuticals Completes End-of-Review Meeting With FDA for AZ-004 (Staccato® Loxapine) NDA 3Alexza Pharmaceuticals Completes End-of-Review Meeting With FDA for AZ-004 (Staccato® Loxapine) NDA 4Alexza Pharmaceuticals Completes End-of-Review Meeting With FDA for AZ-004 (Staccato® Loxapine) NDA 5Alexza Pharmaceuticals Completes End-of-Review Meeting With FDA for AZ-004 (Staccato® Loxapine) NDA 6Emerging Markets Are Gaining Ground in Medical Technology Innovation; U.S. Maintains Lead, Finds PwC's Medical Technology Innovation Scorecard 2Emerging Markets Are Gaining Ground in Medical Technology Innovation; U.S. Maintains Lead, Finds PwC's Medical Technology Innovation Scorecard 3Emerging Markets Are Gaining Ground in Medical Technology Innovation; U.S. Maintains Lead, Finds PwC's Medical Technology Innovation Scorecard 4Emerging Markets Are Gaining Ground in Medical Technology Innovation; U.S. Maintains Lead, Finds PwC's Medical Technology Innovation Scorecard 5
Reference Lab Interface (RLI)© for SRS Software, provides real-time processing of HL7 lab data directly into SRS Freedom Chart ManagerTM, producing an HTML form in the patients chart/tab, whil...
Patient Monitor...
... and a FAM-labeled probe that is designed to ... to detect Flu B. In addition, this ASR ... a separate sample processing control. This ASR requires ... and Texas Red reporter dyes such as the ...
... contains primers and a FAM-labeled probe that ... (RSV). In addition, this ASR contains primers ... sample processing control. This ASR requires an ... Red reporter dyes such as the Cepheid ...
Medicine Products: